Methadone Clinics in Michigan

Methadone clinics in Michigan provide patients with safe, medically assisted treatment for opiate addiction. These programs offer affordable, convenient help to those who need it most.

Methadone Clinics in cities of Michigan

Medication Treatment for Opioid Use Disorder in Michigan

Michigan has spent the past several years rebuilding how people get medication treatment for opioid use disorder (MOUD), and the picture today is different from what it was even three years ago. Methadone, buprenorphine (including Suboxone), and naltrexone are all available across the state, through both opioid treatment programs (OTPs) and office-based prescribers.

In Detroit and the larger metros, you will usually find both options nearby. In rural northern counties and the Upper Peninsula, the closest OTP may be in another town, and telehealth for buprenorphine fills part of the gap.

The listings on this page show clinics in your area. The sections below explain what to expect and how Michigan’s rules and programs work.

Methadone, Suboxone, and Vivitrol

Three medications are approved by the FDA to treat opioid use disorder, and they are not interchangeable. Methadone is a full opioid agonist that quiets withdrawal and cravings. Under federal law it is dispensed for OUD only through a SAMHSA-certified opioid treatment program, not a regular pharmacy.

Buprenorphine, including the Suboxone brand of buprenorphine-naloxone and the monthly Sublocade injection, is a partial agonist. Since the X-waiver was eliminated in 2023, any clinician with a standard DEA registration can prescribe it in an office, and you can fill it at a pharmacy.

Naltrexone, including the monthly Vivitrol injection, is not an opioid at all. It blocks opioid effects, but treatment can only start after you have been off opioids for a set period to avoid sudden withdrawal.

Most people in Michigan start with either methadone at an OTP or buprenorphine through an office-based provider. Which one fits you depends on how long you have used, what you are using now (fentanyl makes induction more sensitive), your daily life, and a clinician’s input.

None of these medications is a substitute drug or an unfinished step. They are the treatment. The side-by-side comparison and the methadone information page go deeper.

Michigan’s Rules, Payment Options, and What Is Covered

Michigan Medicaid covers all three medications for opioid use disorder. The Michigan Department of Health and Human Services removed the prior authorization requirement for MOUD prescriptions for Medicaid beneficiaries, a change the state credits with roughly a 20 percent increase over four years in MOUD prescriptions written by primary care physicians.

Methadone for OUD is dispensed at certified OTPs and is covered through fee-for-service.

Buprenorphine and naltrexone are covered as pharmacy benefits through both fee-for-service and Medicaid Health Plans.

Most commercial plans and Medicare also cover at least one formulation of each medication. Medicare Part B covers methadone delivered through a certified OTP, but Part D does not cover methadone for OUD.

Several federal telehealth pathways for buprenorphine are in effect through at least December 31, 2026, including audio-only visits for OUD, which lets a clinician in Ann Arbor or Marquette start a patient on medication without an initial in-person visit (DEA and HHS, 2025). Methadone induction can also be done by audio-video telehealth within an OTP, but methadone itself still has to be picked up at the OTP.

The 2024 federal update to 42 CFR Part 8 expanded take-home methadone up to a 28-day supply for stable patients. The OTP decides eligibility based on how a person is doing in treatment.

Naloxone has been available without a prescription at Michigan pharmacies since the 2014 statewide standing order (MCL 333.17744b), and Michigan’s Good Samaritan provision (MCL 691.1503) protects people who administer it in good faith from civil liability.

The why your dose matters page covers continuity of care during these transitions, and long-term medication treatment covers what ongoing care looks like.

Why Overdose Deaths Are Falling In Michigan

Michigan is one of the few states where the overdose curve has bent significantly downward. Provisional MDHHS data show statewide drug overdose deaths fell roughly 34 percent between 2023 and 2024, about 1,000 fewer deaths. This is the third straight year of decline and one of the steepest reductions in the country (MDHHS, 2025).

Fentanyl remains the dominant driver of the deaths that still occur, and xylazine has appeared in a growing share of cases.

The state attributes part of the progress to its Naloxone Direct Portal, which has distributed more than 1.3 million free naloxone kits since 2020 with nearly 34,000 reported overdose reversals. Officials also point to the Michigan Opioid Healing and Recovery Fund, which channels settlement dollars into treatment, harm reduction, and reentry programs. The Michigan Overdose Data to Action (MODA) dashboard publishes county-level numbers, and the Michigan Substance Use Vulnerability Index (MI-SUVI) is used to direct funding toward the hardest-hit communities.

The point is not that the crisis is over. Nonfatal overdoses remain high, and racial disparities in death rates have not closed. There is more local capacity now than there has been in years, and the providers on this page are part of that capacity.

The opioid addiction overview covers the medical condition itself in more depth.

Starting Treatment in Michigan

The first step is usually a phone call to a provider listed on this page. An OTP intake will include an assessment, a medical history, a urine drug screen, and an induction visit, often the same day if you arrive during morning dosing hours.

For buprenorphine through an office-based provider, the same assessment happens, and many clinics can do the visit by telehealth, including by phone, and send the prescription to your pharmacy. Bring a photo ID, your insurance card or Medicaid card if you have one, and a list of medications you take.

If you are using fentanyl, tell the clinician. Starting buprenorphine too soon after fentanyl use can trigger sudden, severe withdrawal (precipitated withdrawal), and clinicians now plan that timing carefully, sometimes using low-dose induction methods. The methadone treatment for fentanyl page covers what this looks like for methadone.

Federal practitioners may also dispense up to a three-day supply of methadone to begin treatment while ongoing care is arranged. If a higher level of care is needed first, the inpatient opioid addiction treatment page explains how that fits in.

Reentry, Pregnancy, and Other Situations Michigan Has Built Around

If you or someone you love is leaving a Michigan jail or prison, this is the highest-risk moment for overdose, and the state has invested heavily here. Using opioid settlement funding, MDHHS allocated $2.5 million in fiscal year 2024 to implement MOUD in Michigan Department of Corrections facilities and $500,000 toward developing a Section 1115 Medicaid reentry waiver.

The waiver grants of up to $25,000 per jail available to county facilities prioritized by the state’s Substance Use Vulnerability Index. If the waiver is approved, Medicaid would be able to cover MOUD and case management in the 90 days before release. Ask the facility’s reentry coordinator who their community partner is and request that your medication continue uninterrupted on the day of release.

For pregnancy, methadone and buprenorphine are the standard of care. MDHHS supports rooming-in for parents and babies with neonatal opioid withdrawal syndrome (NOWS) so families stay together during treatment, and northern Michigan health systems have built perinatal MOUD networks through the Opioid Home Health initiative.

Native patients living in or near tribal communities can ask about tribal health program and Indian Health Service pathways alongside the providers on this page.

For families trying to figure out how to help, the information for families page covers what to do and what to expect, and the methadone and pregnancy page covers perinatal care in more depth.

How to Use This Directory

The clinics shown on this page are organized by city. If you live in or near Detroit, Grand Rapids, Lansing, Flint, Kalamazoo, Ann Arbor, or another metro, the closest options are usually a short drive. If you live in the Thumb, the northern Lower Peninsula, or the Upper Peninsula, the nearest OTP may be in a regional hub, and a buprenorphine prescriber by telehealth may be the faster route to your first dose.

Call a clinic to confirm hours, that they are accepting new or transferring patients, which medications they offer, and which insurance plans they take. If you are transferring methadone from another state or another Michigan clinic, ask about the records they need and whether they can arrange guest dosing while paperwork is in motion.

Common Questions About Michigan MOUD

Does Michigan Medicaid cover Suboxone and methadone?

Yes. Michigan Medicaid covers buprenorphine products (including Suboxone), naltrexone (including Vivitrol), and methadone for opioid use disorder. Methadone is covered under fee-for-service through certified OTPs. Buprenorphine and naltrexone are pharmacy benefits under both fee-for-service and Medicaid Health Plans. Prior authorization for MOUD prescriptions was removed in 2024 to widen access.

Can I start Suboxone by telehealth in Michigan?

Yes. Under federal flexibilities currently in effect through December 31, 2026, including audio-only visits for opioid use disorder, a Michigan-licensed clinician can prescribe buprenorphine without a prior in-person visit. Permanent federal rules are being finalized, so confirm with the provider what is current at the time of your visit.

How is methadone different from Suboxone day to day?

Methadone for OUD requires dosing at a certified opioid treatment program, daily at first, with take-home doses earned as a person stabilizes, (Federal rules now permit up to a 28-day supply for stable patients.)

Suboxone and other buprenorphine products are picked up at a pharmacy and taken at home from the start. Methadone is generally more effective for severe, long-standing dependence. Buprenorphine carries a lower overdose risk on its own. The choice belongs to you and a clinician.

Where can I get naloxone in Michigan?

Naloxone is available at Michigan pharmacies without an individual prescription under the state’s standing order, including over-the-counter Narcan nasal spray, and free kits are distributed through community organizations enrolled in MDHHS’s Naloxone Direct Portal. Michigan’s Good Samaritan law (MCL 691.1503) protects people who administer it in good faith. The overdose safety page covers how to recognize an overdose and respond.

What if a return to opioid use happens during treatment?

A return to use is common in opioid use disorder and is treated as a clinical event, not a failure. The right response is to stay engaged with the clinic, talk to the provider, and adjust the plan, which may mean a different dose, more frequent visits, more support, or a different medication.

Discharge from treatment is not the answer. The questions and answers page covers more of the recurring questions people have.

Sources and Page Info

Last reviewed: June 2026.

Sources:

Michigan Department of Health and Human Services. “Michigan Projects Third Consecutive Year of Decline in Opioid Overdose Deaths.” June 2025. michigan.gov
Michigan Department of Health and Human Services. “Michigan’s overdose death rate declines nearly five times faster than national average.” November 2024. michigan.gov
Michigan Attorney General. “Michigan Projects Third Consecutive Year of Decline in Opioid Overdose Deaths.” June 2025. michigan.gov/ag
NASHP. “A Braided Funding Approach: Leveraging Opioid Settlement Funds to Strengthen Supports for Justice-Involved Populations.” 2024. nashp.org
Michigan Department of Health and Human Services. “Naloxone Standing Order for Pharmacist Use Only.” michigan.gov
Michigan Legislature. MCL 691.1503, opioid antagonist Good Samaritan provision. legislature.mi.gov
U.S. Drug Enforcement Administration and HHS. “Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications.” Federal Register, December 31, 2025. federalregister.gov
SAMHSA. “DEA and HHS Issue Final Telemedicine Rule for Buprenorphine Access.” 2025. samhsa.gov
SAMHSA. 42 CFR Part 8 final rule, 2024. samhsa.gov

Methadone Centers is a directory and education resource, not a treatment provider. We do not diagnose, prescribe, or deliver care. Information here is general and is not a substitute for advice from a licensed clinician.

Calls to numbers listed on this site may be answered by a paid sponsor of the helpline. The helpline is free and confidential, and there is no obligation to enter treatment. Methadone Centers receives compensation for paid placements.

Call For Help With Addiction

Talk To Someone Now